Plerixafor offers several benefits in the context of cancer treatment:
Increased efficiency of stem cell collection, reducing the number of apheresis sessions needed. Improved outcomes for patients who previously failed to mobilize sufficient HSCs with G-CSF alone. Potential to reduce the overall time and cost associated with the stem cell mobilization process.
